RAC 1.11% $1.83 race oncology ltd

Ann: FDA RPD Designation Granted for RC220 Bisantrene, page-60

  1. 2,664 Posts.
    lightbulb Created with Sketch. 3252
    @reon1

    RAC hasn't submitted an NDA since 2019. They don't intend to submit another until 1H 2025.

    The entire clinical strategy revolves around exploring the greatest ROI for investors for the least amount of outlay BEFORE committing to a US registrational trial. One of the reasons there's so few SOI.

    The peadiatric AML PRV is one of numerous commercialisation strategies on offer. Shareholders are aware of this.
    Last edited by johndprent: 18/06/24
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.83
Change
0.020(1.11%)
Mkt cap ! $310.7M
Open High Low Value Volume
$1.81 $1.83 $1.79 $142.0K 78.77K

Buyers (Bids)

No. Vol. Price($)
1 500 $1.81
 

Sellers (Offers)

Price($) Vol. No.
$1.83 641 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.